Loading clinical trials...
Loading clinical trials...
A Study on the Impact of Bivalirudin Usage During Percutaneous Coronary Intervention for High-risk Plaques in the Coronary Artery on Post Percutaneous Coronary Intervention Coronary Microcirculation.
Conditions
Interventions
Bivalirudin
standard heparin
Locations
1
China
Peking university first hospital
Beijing, Beijing Municipality, China
Start Date
July 1, 2023
Primary Completion Date
December 1, 2025
Completion Date
January 4, 2026
Last Updated
August 12, 2025
NCT07093528
NCT06991322
NCT06795035
NCT06597851
NCT06503640
NCT05960474
Lead Sponsor
Peking University First Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions